Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.


TSX:GUD - Post by User

Bullboard Posts
Post by bbzzzzon Nov 12, 2017 2:16pm
267 Views
Post# 26947782

The Private Equity or Miner of Pharmaceuticals !

The Private Equity or Miner of Pharmaceuticals !Yes, this is how view GUD .
 Mr.Goodman has various preferred convertible equity investments that are attached to rights and offerings in the future all the while collecting 10% to 15% on pharma based companies. ( Warren Buffet or Prem Wasa approach)
At the same time he is developing relationships with other pharma firms around the world solidifying his presence when the opportunities arise by having interownership structures.
 All of this is happening as the competition is drowning in debt while GUD is floating in cash which is really the greatest option you can leave open at this point. Patience ..... How do you quantify that?
 Gud is also putting out new products and marketing them via a direct sales force. This is the true investment he is making now . It is in people to get the new products to market . A dedicated sales force is a huge asset when new products come avaliable .
On top of all this Mr.Goodman and team have done this before with great success !! 
I feel the second time around should be easier considering most of the mistakes may have been ironed out from the first time success.
 I really love the private equity aspect of this position . It really is a Miner of pharmaceutical products.
 Thanks for allowing me to share my thoughts on GUD ! It is so GUD of you all to have read this and I hope it may stimulate further GUD stuff amongst us investors!
Tedz
Bullboard Posts